889 related articles for article (PubMed ID: 11839570)
1. Retinal vascular endothelial growth factor induces intercellular adhesion molecule-1 and endothelial nitric oxide synthase expression and initiates early diabetic retinal leukocyte adhesion in vivo.
Joussen AM; Poulaki V; Qin W; Kirchhof B; Mitsiades N; Wiegand SJ; Rudge J; Yancopoulos GD; Adamis AP
Am J Pathol; 2002 Feb; 160(2):501-9. PubMed ID: 11839570
[TBL] [Abstract][Full Text] [Related]
2. Suppression of diabetic retinopathy with angiopoietin-1.
Joussen AM; Poulaki V; Tsujikawa A; Qin W; Qaum T; Xu Q; Moromizato Y; Bursell SE; Wiegand SJ; Rudge J; Ioffe E; Yancopoulos GD; Adamis AP
Am J Pathol; 2002 May; 160(5):1683-93. PubMed ID: 12000720
[TBL] [Abstract][Full Text] [Related]
3. Nonsteroidal anti-inflammatory drugs prevent early diabetic retinopathy via TNF-alpha suppression.
Joussen AM; Poulaki V; Mitsiades N; Kirchhof B; Koizumi K; Döhmen S; Adamis AP
FASEB J; 2002 Mar; 16(3):438-40. PubMed ID: 11821258
[TBL] [Abstract][Full Text] [Related]
4. Integrin-mediated neutrophil adhesion and retinal leukostasis in diabetes.
Barouch FC; Miyamoto K; Allport JR; Fujita K; Bursell SE; Aiello LP; Luscinskas FW; Adamis AP
Invest Ophthalmol Vis Sci; 2000 Apr; 41(5):1153-8. PubMed ID: 10752954
[TBL] [Abstract][Full Text] [Related]
5. VEGF-initiated blood-retinal barrier breakdown in early diabetes.
Qaum T; Xu Q; Joussen AM; Clemens MW; Qin W; Miyamoto K; Hassessian H; Wiegand SJ; Rudge J; Yancopoulos GD; Adamis AP
Invest Ophthalmol Vis Sci; 2001 Sep; 42(10):2408-13. PubMed ID: 11527957
[TBL] [Abstract][Full Text] [Related]
6. Inducible nitric oxide synthase isoform is a key mediator of leukostasis and blood-retinal barrier breakdown in diabetic retinopathy.
Leal EC; Manivannan A; Hosoya K; Terasaki T; Cunha-Vaz J; Ambrósio AF; Forrester JV
Invest Ophthalmol Vis Sci; 2007 Nov; 48(11):5257-65. PubMed ID: 17962481
[TBL] [Abstract][Full Text] [Related]
7. Role of alpha 4 integrin (CD49d) in the pathogenesis of diabetic retinopathy.
Iliaki E; Poulaki V; Mitsiades N; Mitsiades CS; Miller JW; Gragoudas ES
Invest Ophthalmol Vis Sci; 2009 Oct; 50(10):4898-904. PubMed ID: 19553613
[TBL] [Abstract][Full Text] [Related]
8. VEGF164 is proinflammatory in the diabetic retina.
Ishida S; Usui T; Yamashiro K; Kaji Y; Ahmed E; Carrasquillo KG; Amano S; Hida T; Oguchi Y; Adamis AP
Invest Ophthalmol Vis Sci; 2003 May; 44(5):2155-62. PubMed ID: 12714656
[TBL] [Abstract][Full Text] [Related]
9. Simvastatin inhibits leukocyte accumulation and vascular permeability in the retinas of rats with streptozotocin-induced diabetes.
Miyahara S; Kiryu J; Yamashiro K; Miyamoto K; Hirose F; Tamura H; Katsuta H; Nishijima K; Tsujikawa A; Honda Y
Am J Pathol; 2004 May; 164(5):1697-706. PubMed ID: 15111316
[TBL] [Abstract][Full Text] [Related]
10. Aldose reductase inhibitor fidarestat attenuates leukocyte-endothelial interactions in experimental diabetic rat retina in vivo.
Hattori T; Matsubara A; Taniguchi K; Ogura Y
Curr Eye Res; 2010 Feb; 35(2):146-54. PubMed ID: 20136425
[TBL] [Abstract][Full Text] [Related]
11. Experimental diabetes causes breakdown of the blood-retina barrier by a mechanism involving tyrosine nitration and increases in expression of vascular endothelial growth factor and urokinase plasminogen activator receptor.
El-Remessy AB; Behzadian MA; Abou-Mohamed G; Franklin T; Caldwell RW; Caldwell RB
Am J Pathol; 2003 Jun; 162(6):1995-2004. PubMed ID: 12759255
[TBL] [Abstract][Full Text] [Related]
12. Vascular endothelial growth factor up-regulates the expression of intracellular adhesion molecule-1 in retinal endothelial cells via reactive oxygen species, but not nitric oxide.
Zhang XL; Wen L; Chen YJ; Zhu Y
Chin Med J (Engl); 2009 Feb; 122(3):338-43. PubMed ID: 19236815
[TBL] [Abstract][Full Text] [Related]
13. Vascular endothelial growth factor and its receptors in control and diabetic rat eyes.
Gilbert RE; Vranes D; Berka JL; Kelly DJ; Cox A; Wu LL; Stacker SA; Cooper ME
Lab Invest; 1998 Aug; 78(8):1017-27. PubMed ID: 9714188
[TBL] [Abstract][Full Text] [Related]
14. Acute intensive insulin therapy exacerbates diabetic blood-retinal barrier breakdown via hypoxia-inducible factor-1alpha and VEGF.
Poulaki V; Qin W; Joussen AM; Hurlbut P; Wiegand SJ; Rudge J; Yancopoulos GD; Adamis AP
J Clin Invest; 2002 Mar; 109(6):805-15. PubMed ID: 11901189
[TBL] [Abstract][Full Text] [Related]
15. Rho kinase inhibition by fasudil ameliorates diabetes-induced microvascular damage.
Arita R; Hata Y; Nakao S; Kita T; Miura M; Kawahara S; Zandi S; Almulki L; Tayyari F; Shimokawa H; Hafezi-Moghadam A; Ishibashi T
Diabetes; 2009 Jan; 58(1):215-26. PubMed ID: 18840783
[TBL] [Abstract][Full Text] [Related]
16. Vascular endothelial growth factor (VEGF)-induced retinal vascular permeability is mediated by intercellular adhesion molecule-1 (ICAM-1).
Miyamoto K; Khosrof S; Bursell SE; Moromizato Y; Aiello LP; Ogura Y; Adamis AP
Am J Pathol; 2000 May; 156(5):1733-9. PubMed ID: 10793084
[TBL] [Abstract][Full Text] [Related]
17. Protective effects of a coumarin derivative in diabetic rats.
Bucolo C; Ward KW; Mazzon E; Cuzzocrea S; Drago F
Invest Ophthalmol Vis Sci; 2009 Aug; 50(8):3846-52. PubMed ID: 19279317
[TBL] [Abstract][Full Text] [Related]
18. VEGF increases retinal vascular ICAM-1 expression in vivo.
Lu M; Perez VL; Ma N; Miyamoto K; Peng HB; Liao JK; Adamis AP
Invest Ophthalmol Vis Sci; 1999 Jul; 40(8):1808-12. PubMed ID: 10393052
[TBL] [Abstract][Full Text] [Related]
19. Aquaporin 4 knockdown exacerbates streptozotocin-induced diabetic retinopathy through aggravating inflammatory response.
Cui B; Sun JH; Xiang FF; Liu L; Li WJ
Exp Eye Res; 2012 May; 98():37-43. PubMed ID: 22449442
[TBL] [Abstract][Full Text] [Related]
20. An endothelin type A receptor antagonist reverses upregulated VEGF and ICAM-1 levels in streptozotocin-induced diabetic rat retina.
Masuzawa K; Goto K; Jesmin S; Maeda S; Miyauchi T; Kaji Y; Oshika T; Hori S
Curr Eye Res; 2006 Jan; 31(1):79-89. PubMed ID: 16421022
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
